◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2225

Jinhai Medical Technology Limited (2225) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Industrials · Staffing & Employment Services · DATA UPDATED 2026-08-11

Jinhai Medical Technology Limited (2225) operates in the Staffing & Employment Services industry and is headquartered in Wan Chai, Hong Kong with about 485 employees. Its market capitalization is roughly SGD 26 billion. In the fiscal year ended 2025-12-31, 2225 reported SGD 46M in revenue and (SGD 17M) in net income.

Jinhai Medical Technology Limited, an investment holding company, provides minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore. It also offers manpower outsourcing and ancillary services to building and construction contractors.

Interactive charts & full statements →

2225 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueSGD 46MSGD 50MSGD 46MSGD 22M
Gross ProfitSGD 7MSGD 12MSGD 12MSGD 10M
Operating Income (EBIT)(SGD 18M)(SGD 20M)(SGD 4M)SGD 0M
Net Income(SGD 17M)(SGD 18M)(SGD 3M)SGD 0M

SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2225 Free Cash Flow History

2225 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsSGD 89MSGD 59MSGD 62MSGD 40M
Total LiabilitiesSGD 37MSGD 26MSGD 25MSGD 16M

SGD; SGDM / SGDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2225 viewer.

Other Companies in Staffing & Employment Services

← 2224All “0-9” companies2226 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.